Molecular profiling of peripheral blood cells from patients with polycythemia vera and related neoplasms: Identification of deregulated genes of significance for inflammation and immune surveillance

被引:58
作者
Skov, Vibe [2 ]
Larsen, Thomas Stauffer [3 ]
Thomassen, Mads [2 ]
Riley, Caroline Hasselbalch [4 ]
Jensen, Morten K. [4 ]
Bjerrum, Ole Weis [5 ]
Kruse, Torben A. [2 ]
Hasselbalch, Hans Carl [1 ]
机构
[1] Univ Copenhagen, Roskilde Hosp, Dept Hematol, Roskilde, Denmark
[2] Odense Univ Hosp, Dept Clin Genet, DK-5000 Odense, Denmark
[3] Odense Univ Hosp, Dept Hematol X, DK-5000 Odense, Denmark
[4] Univ Copenhagen, Herlev Hosp, Dept Hematol L, Copenhagen, Denmark
[5] Univ Copenhagen, Rigshosp, Dept Hematol L, DK-2100 Copenhagen, Denmark
关键词
Philadelphia-negative chronic myeloproliferative neoplasms; Whole blood gene expression profiling; Inflammation; Immunoregulation; Microarray; CHRONIC MYELOPROLIFERATIVE NEOPLASMS; ENDOTHELIAL GROWTH-FACTOR; REGULATORY T-CELLS; ESSENTIAL THROMBOCYTHEMIA; PRIMARY MYELOFIBROSIS; IDIOPATHIC MYELOFIBROSIS; VENOUS THROMBOSIS; RISK-FACTORS; IFN-ALPHA; EXPRESSION;
D O I
10.1016/j.leukres.2012.07.009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Essential thrombocythemia (ET), polycythemia vera (PV) and primary myelofibrosis (PMF) are hematopoietic stem cell neoplasms that may be associated with autoimmune or chronic inflammatory disorders. Earlier gene expression profiling studies have demonstrated aberrant expression of genes involved in inflammatory responses, mainly being performed on granulocytes or CD34+ cells. Using gene expression profiling of whole blood from patients with ET (n = 16), PV (n = 36), and PMF (n = 9), several genes involved in inflammation and immune regulation were found to be significantly deregulated. Our findings may reflect chronic inflammation to be of pathogenetic importance for the progression of these neoplasms toward the myelofibrotic end-stage and may also account for the increased frequency of second cancer in these diseases. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1387 / 1392
页数:6
相关论文
共 50 条
  • [1] Inflammation and thrombosis in essential thrombocythemia and polycythemia vera: different role of C-reactive protein and pentraxin 3
    Barbui, Tiziano
    Carobbio, Alessandra
    Finazzi, Guido
    Vannucchi, Alessandro M.
    Barosi, Giovanni
    Antonioli, Elisabetta
    Guglielmelli, Paola
    Pancrazzi, Alessandro
    Salmoiraghi, Silvia
    Zilio, Pio
    Ottomano, Cosimo
    Marchioli, Roberto
    Cuccovillo, Ivan
    Bottazzi, Barbara
    Mantovani, Alberto
    Rambaldi, Alessandro
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (02): : 315 - 318
  • [2] Transcriptional Profiling of Polycythemia Vera Identifies Gene Expression Patterns Both Dependent and Independent from the Action of JAK2V617F
    Berkofsky-Fessler, Windy
    Buzzai, Monica
    Kim, Marianne K-H.
    Fruchtman, Steven
    Najfeld, Vesna
    Min, Dong-Joon
    Costa, Fabricio F.
    Bischof, Jared M.
    Soares, Marcelo B.
    McConnell, Melanie Jane
    Zhang, Weijia
    Levine, Ross
    Gilliland, D. Gary
    Calogero, Raffaele
    Licht, Jonathan D.
    [J]. CLINICAL CANCER RESEARCH, 2010, 16 (17) : 4339 - 4352
  • [3] MACROPHAGE DEACTIVATION BY INTERLEUKIN-10
    BOGDAN, C
    VODOVOTZ, Y
    NATHAN, C
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (06) : 1549 - 1555
  • [4] Anti-inflammatory cytokines hepatocyte growth factor and interleukin-11 are over-expressed in Polycythemia vera and contribute to the growth of clonal erythroblasts independently of JAK2V617F
    Boissinot, M.
    Cleyrat, C.
    Vilaine, M.
    Jacques, Y.
    Corre, I.
    Hermouet, S.
    [J]. ONCOGENE, 2011, 30 (08) : 990 - 1001
  • [5] Evaluation of the bioactive and total transforming growth factor β1 levels in primary myelofibrosis
    Campanelli, Rita
    Rosti, Vittorio
    Villani, Laura
    Castagno, Marta
    Moretti, Enza
    Bonetti, Elisa
    Bergamaschi, Gaetano
    Balduini, Alessandra
    Barosi, Giovanni
    Massa, Margherita
    [J]. CYTOKINE, 2011, 53 (01) : 100 - 106
  • [6] Mechanisms of disease: The myeloproliferative disorders
    Campbell, Peter J.
    Green, Anthony R.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (23) : 2452 - 2466
  • [7] Leukocytosis and risk stratification assessment in essential thrombocythemia
    Carobbio, Alessandra
    Antonioli, Elisabetta
    Guglielmelli, Paola
    Vannucchi, Alessandro M.
    Delaini, Federica
    Guerini, Vittoria
    Finazzi, Guido
    Rambaldi, Alessandro
    Barbui, Tiziano
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (16) : 2732 - 2736
  • [8] Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients
    Carobbio, Alessandra
    Thiele, Juergen
    Passamonti, Francesco
    Rumi, Elisa
    Ruggeri, Marco
    Rodeghiero, Francesco
    Randi, Maria Luigia
    Bertozzi, Irene
    Vannucchi, Alessandro M.
    Antonioli, Elisabetta
    Gisslinger, Heinz
    Buxhofer-Ausch, Veronika
    Finazzi, Guido
    Gangat, Naseema
    Tefferi, Ayalew
    Barbui, Tiziano
    [J]. BLOOD, 2011, 117 (22) : 5857 - 5859
  • [9] Molecular profile of CD34+stem/progenitor cells according to JAK2V617F mutation status in essential thrombocythemia
    Catani, L.
    Zini, R.
    Sollazzo, D.
    Ottaviani, E.
    Vannucchi, A. M.
    Ferrari, S.
    Baccarani, M.
    Vianelli, N.
    Lemoli, R. M.
    Manfredini, R.
    [J]. LEUKEMIA, 2009, 23 (05) : 997 - 1000
  • [10] Hepatocyte Growth Factor Modulates Interleukin-6 Production in Bone Marrow Derived Macrophages: Implications for Inflammatory Mediated Diseases
    Coudriet, Gina M.
    He, Jing
    Trucco, Massimo
    Mars, Wendy M.
    Piganelli, Jon D.
    [J]. PLOS ONE, 2010, 5 (11):